Haig Aghajanian

Haig Aghajanian

Company: Capstan Therapeutics

Job title: Vice President of Research


CAR-T Cell Therapy for the Treatment of Fibrotic Conditions 10:30 am

CAR-T cells can be used to target pathogenic cardiac fibroblasts CAR-T cell ablation of pathogenic fibroblasts in an injured heart reduces fibrosis and restores function This principle can be applied to various fibrotic pathologiesRead more

day: Focus Day - Track A - Morning

Workshop A: In Vivo Production of Functional CAR-T Cells by mRNA Targeted Lipid Nanoparticles 9:00 am

Targeted lipid nanoparticles can effectively reprogramme T-cells in vivo to express a CAR CAR-T cells produced in this manner are functional and can ameliorate pathologyRead more

day: Workshop - Track A - Morning

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.